First Domestic Approval of AI Medical Device Assisting in Depression Diagnosis
Quantifying Depression Probability Based on Interview Record Data
The Ministry of Food and Drug Safety announced on the 23rd that it approved a software medical device indicating the probability of depression (product name ACRYL-D01) on the 20th.
Developed by Acryl, an artificial intelligence (AI) specialized company, this product analyzes interview records between medical professionals and patients using AI to quantify the probability of depression, assisting psychiatrists in diagnosing depression. It is the first software in Korea approved for detecting depression.
The Ministry of Food and Drug Safety plans to actively work to expand treatment opportunities for diseases that have been difficult to diagnose and predict by supplying new AI-based software medical devices, based on regulatory science expertise.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "Hancom Breaks Away from Its 36-Year Mission and Formula for Success" (Comprehensive)
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
An official from the Ministry stated, "Using the depression screening results predicted by this software, clinicians will be able to diagnose depression early in patients with depressive disorders and contribute to mental health management through continuous treatment."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
